Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Recruiting · NCT07467993 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 2 | 2026-07-29 | NCT07467993 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arch Clinical Trials LLC | St Louis | United States | 1 |
| CenExel iResearch | Decatur | United States | 4 |
| CNRI Los Angeles LLC | Pico Rivera | United States | 1 |
| Pillar Clinical Research LLC | Bentonville | United States | 1 |
| Pillar Clinical Research LLC | Chicago | United States | 2 |
| Segal Institute for Clinical Research | Miami | United States | 1 |
| Uptown Research Institute LLC | Chicago | United States | 1 |